These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 8253229

  • 1. Pilocarpine drops do not reduce intraocular pressure sufficiently in pseudoexfoliation glaucoma.
    Brinchmann-Hansen O, Albrektsen T, Anmarkrud N.
    Eye (Lond); 1993; 7 ( Pt 4)():511-6. PubMed ID: 8253229
    [Abstract] [Full Text] [Related]

  • 2. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG.
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [Abstract] [Full Text] [Related]

  • 3. [Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action].
    Andermann C, Mialhe D, Arne JL, Vende D, Bec P.
    J Fr Ophtalmol; 1983 Feb; 6(4):367-74. PubMed ID: 6350412
    [Abstract] [Full Text] [Related]

  • 4. Pilocarpine medication in open-angle glaucoma. A study using pilocarpine eyedrops and an ocular therapeutic system.
    Brinchmann-Hansen O, Anmarkrud N.
    Acta Ophthalmol (Copenh); 1979 Feb; 57(1):55-62. PubMed ID: 419977
    [Abstract] [Full Text] [Related]

  • 5. [Pilocarpine-ocusert-p-40 in the handicapped glaucoma patient (author's transl)].
    Krieglstein GK.
    Klin Monbl Augenheilkd; 1975 Jul; 167(1):55-61. PubMed ID: 1104988
    [Abstract] [Full Text] [Related]

  • 6. The long-acting Ocusert-pilocarpine system in the management of glaucoma.
    Lee P, Shen Y, Eberle M.
    Invest Ophthalmol; 1975 Jan; 14(1):43-6. PubMed ID: 1110136
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
    Ren J, Shin DH, Chung HS, Birt CM, Glover BK, Juzych MS, Hughes BA, Kim C.
    Ophthalmology; 1999 Jun; 106(6):1135-9. PubMed ID: 10366082
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.
    Reis R, dos Santos LC, Vila MP, Magacho L.
    Clin Ther; 2004 Dec; 26(12):2121-7. PubMed ID: 15823775
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T, Gross R, Pearson J, Rusk C, Adamsons I.
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J, Sobecki R, Czechowicz-Janicka K, Kecik D, Kałuzny BJ, Stewart JA, Stewart WC.
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.